HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCES

Oracle’s position in the Life Sciences Industry

Charles Scatchard, Vice President Healthcare and Life Sciences EMEA

Oracle France Pharma Day

Paris, October 13th, 2005

2

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESThe LS value chain

Patients

Suppliers Payers / Regulators

Pharmaceutical

Medical Eqpt

Integrated

Networks

Hospitals

PrimaryCare

Outpatient

Other

Biotech

Distributor/Wholesaler

Regulatory

Agency

Physicians

Payer

Employer

Providers

Retailer

Discovery

Pharmaceutical Mfg Plant

Development

Manufacturing, Salesand Marketing Hospital

Pharmacy

Distribution

Biotech /PharmaceuticalResearch Labs

Wet Lab

In Silico

Contract Research Organization

PharmaceuticalCompany

RegulatoryAgency

Clinical T

rials

Clinical T

rials

BiomedicalFirm

BiomedicalFirm

PharmaceuticalCompany

Pre-Clinical T

rials

Pre-Clinical T

rials

Public/Private Data

SampleData

3

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCES… is completely covered by Oracle

Discovery• High performance GRID computing• BLAST Algorithm and other Search Tools

Development• Oracle Pharmaceutical Application (OPA) suite: Clinical Data

Management & Remote Data Capture, Thesaurus Management, Adverse Events Reporting, Clinical Trials Management

Manufacturing, Sales and Marketing• CRF part 11 compliant Manufacturing• ERP (Financial, HR, Procurement)• Customer Relationship Management

Common foundation• Technology stack (performance, scalability, security, etc.)• Data structures• Business Intelligence and Data Warehousing

4

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESOracle LS footprint

28 of top 30 pharma • Pfizer, GlaxoSmithKline, Merck, Johnson & Johnson, Sanofi-Aventis, AstraZeneca,

Novartis, Bristol-Myers Squibb, Wyeth, Eli Lilly, Abbott Labs, Roche, Boehringer Ingelheim, Amgen, Takeda, Schering-Plough, Schering AG, Bayer, Sankyo, Yamanouchi, Novo Nordisk, Merck KGaA, Teva, Baxter, Akzo Nobel, Fujisawa, Genentech

75% of CROs

20 research organizations • incl. National Cancer Institute

16 of top 20 Medical Device• Johnson and Johnson, GE Medical Systems, Baxter International, Tyco Healthcare,

Medtronic, Philips Medical Systems, Roche Diagnostics, Abbott Laboratories, Guidant, Stryker, B. Braun, Boston Scientific, Becton, Dickinson & Co., Cardinal Health, Smith & Nephew

5

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESOPA seen by independent research

6

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESConvergence of HC & LS

What we are seeing?• Convergence of standards• Frustration with or lack of data re-use • Personalized medicine• Life Sciences focus on disease management• Emerging eHealth initiatives worldwide

- Brailer initiative, NHIN, UK (National Spine), Sweden, etc.

Why is important?• Traditional data capture and EDC haven’t realized full potential

benefits: process is still inherently inefficient

7

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESConvergence of HC & LS

How are we helping our customers?• Driving the standards (HL7/CDISC)

- Integrate clinical applications with healthcare solutions• Real time clinical information• Single data capture• Working with strategic partners who share of “patient-centric”

approach to clinical data management- Data integration for drug discovery- Cohort identification- Future: Controls re-use in multiple studies

8

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESLong-term strategy: Revolution

Complete migration of all HC and LS applications (Project Fusion)• Process flows through entire suite

• Harmonization of all Pharma (OPA) and HC (HTB) data models

Focus on Business Intelligence• Patient-centric data

• Product Lifecycle Management

Translational Research• Semantic Web (RDF) as basis of Knowledge management

Driving Healthcare – Life Sciences convergence

9

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCES

AQ&Q U E S T I O N S

A N S W E R S

10

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCES

11

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESUNUSED / BACKUP

12

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCES

IncreaseStakeholder

Value

Strategic imperatives in LS

Decreasing R&D productivity and

expiration of blockbuster patents

Pressure in health systems to reduce cost of care and

increase patient safety

Less well understood disease mechanisms on the basis of Genomic /

Proteomic research

Sustain Innovation Increase productivity in R&D Capitalize on internal and external information

Manage Risk Ensure patient safety Manage compliance

Increase profitability Sustain top line growth Reduce costs

Oracle’s approach

13

HEALTHCARE and LIFE SCIENCESHEALTHCARE and LIFE SCIENCESLS/HC platform: Long range vision

E-Business Data Repository

Healthcare Data

Repository

IntegrationEngine

Standards BasedMessaging

Clinical Systems

ResearchSystems

E-BusinessSuite

Healthcare Transaction Base

Clinical Trails

ResearchApplications